{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-052481","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.530181+00:00","generated_at":"2026-06-02T23:12:13.518047+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Fulgent Q1 2024 core revenue $63.2M (+1% YoY), GAAP loss $0.45/share, reiterates FY guidance","bullets":["Total revenue $64.5M; core revenue $63.2M (+1% YoY); FY2024 core revenue guidance reiterated at $280M.","GAAP net loss $13.5M ($0.45 diluted loss per share); Non-GAAP loss $269K ($0.01 per share).","Adjusted EBITDA loss $3.2M; cash from operations $7.3M in Q1.","Cash, cash equivalents, and marketable securities $846.2M as of March 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-052481","json":"https://secwatch.observer/filing/0000950170-24-052481.json","markdown":"https://secwatch.observer/filing/0000950170-24-052481.md","text":"https://secwatch.observer/filing/0000950170-24-052481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024052481/0000950170-24-052481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024052481/flgt-20240503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:12:13.518047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b4bb85b8ba704058240dfb53219512a78a17f420","claim":"Fulgent Genetics, Inc. reported first quarter ended March 31, 2024 results: revenue $64.5 million, net income loss of $13.5 million, EPS $0.45 per share. Guidance reaffirmed.","evidence_excerpt":"Fulgent Reports First Quarter 2024 Financial Results • Total Revenue of $64.5 million • Core Revenue grows 1% year-over-year to $63.2 million • Reiterates Full Year 2024 Core Revenue Guidance of $280 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024052481/0000950170-24-052481-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$64.5 million"},{"label":"Net income","value":"loss of $13.5 million"},{"label":"EPS","value":"$0.45 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}